Loading...
XNAS
LKFT
Market cap1.85bUSD
Sep 18, Last price  
28.55USD
1D
-1.25%
1Q
0.88%
Jan 2017
-55.52%
IPO
140.93%
Name

Galapagos NV

Chart & performance

D1W1MN
XNAS:LKFT chart
P/E
5.10
P/S
1.47
EPS
4.87
Div yield, %
—
Shrs. gr., 5y
0.25%
Rev. gr., 5y
18.40%
Revenues
1.11b
+303.50%
35,152,00065,936,00076,978,00093,089,000122,410,00095,887,000136,268,000137,699,00069,368,00039,563,000129,517,000127,087,000288,836,000834,901,000478,053,000484,846,000241,249,000239,724,000275,649,0001,112,248,000
Net income
321m
+333.15%
-11,335,000-21,948,000-14,584,0003,010,0004,370,000-33,097,000-5,721,000-8,079,00033,211,000-118,410,00054,012,000-115,704,000-29,259,000149,845,000-305,436,000-125,422,000-217,991,000211,697,00074,082,000320,884,000
CFO
-189m
L-40.87%
-9,310,000371,000-8,209,0006,303,000-18,573,000-11,991,00064,104,000522,000-75,555,000-114,590,000239,403,000-147,030,000-142,466,0003,596,902,458-427,336,000-503,827,000-500,544,000-405,970,000-320,026,000-189,232,624

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Related entities

Subsidiaries
Galapagos Cell Therapeutics

Key people

Rajesh B. Parekh
Non-Executive Chairman of the Board · since 2004
Bart Filius
Member of the Executive Committee, Chief Financial Officer, Chief Operating Officer · since 2017
Elizabeth Goodwin
VP Corporate Communications & Investor Relations
Walid Abi-Saab
Member of the Executive Committee, Chief Medical Officer · since 2017
Andre Hoekema
Member of the Executive Committee, Chief Business Officer
Piet Wigerinck
Member of the Executive Committee, Chief Scientific Officer · since 2012
Katrine Bosley
Non-Executive Independent Director · since 2013
Linda Higgins
Non-Executive Independent Director · since 2019
Howard Rowe
Non-Executive Independent Director · since 2010
URL
https://www.glpg.com/
IPO date
May 06, 2005
Employees
1,233
Domiciled in
BE
Incorporated in
BE
Headquarters & legal address
Schaliënhoevedreef 20T
Mechelen 2800
BE
Previous name
GALAPAGOS

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT